300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Film
Oil and Gas
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Japan
Puerto Rico
Poland
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Bangladesh
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Michael Fainshtein, Angel Investor

Michael Fainshtein

Angel Investor

Michael Fainshtein is a seed investor focused on Sensor and Robotics. Michael Fainshtein

Total investments:
2
Last investment:
Lead investor:
50%

Last updated:

Industries Michael Fainshtein invests in

SensorRoboticsSoftwareHealth CareBiotechnology

Stages Michael Fainshtein invests in

Seed

Countries Michael Fainshtein invests in

United States

Round sizes

Seed $700k–$1.3M

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$700k–$1.3M

Investment Focus

Industry

  • Sensor 1 (50%)
  • Robotics 1 (50%)
  • Software 1 (50%)
  • Health Care 1 (50%)
  • Biotechnology 1 (50%)
See all 10 industries →

Investments

CompanyDescriptionRoundLinks
IoT and IoMT (Healthcare IoT) creation require ever-increasing and sophisticated electronic design. It also demands a superior level of expertise and necessitates the need for experienced and highly professional companies to expedite the development process. At the core of every electronic product is the electronics (hardware) and firmware(software) needed to run it.Mircod experience and multi-disciplines enable the company to provide turnkey development of: • Circuit Schematics: Analog & Digital, Gerber Artwork, and Layout Design. • Embedded Systems. • Firmware & Micro Controller Programming Software Design. • User-Interface Development. • Hardware Design for CE, FCE, UL, ROHS, WEEE, and FDA.The ability to provide the right, properly “up and running” comprehensive prototype for the desired idea, while selecting the precise components, defines all aspects of a product's performance, realistic proof of concept, durability, cost, and successful market penetration.MIRCOD brings together personnel with substantive expertise in all primary disciplines required to deliver the most complicated hardware and software solutions. This flexible and multi-skilled team brings an inherent understanding of the R&D in hardware and software related activities and the interfaces with other system delivery disciplines (mathematical algorithms, system engineering, sourcing, advanced materials, and manufacturing) required for success. MIRCOD also has the advantage of having worked on a diverse range of activities across a varied customer base in both production and prototyping capacities.BIOTECHNOLOGY Industry - MIRCOD actively participates in R&D projects initiated by international consortiums. Gene therapy technology developed in consideration with international top cell and gene biotech companies and universities, guarantees to transform tomorrow's medicine by treating the causes of disease rather than the manifestations.IoT Industry - We make the Internet of Things easy from Sketch to Scale. MIRCOD white-labeled rapid IoT web-based platform for rapid design, prototyping, design, and manufacturing is a hardware and software-agnostic system with white-label mobile apps, private BA and BI, complete device management, custom-defined analytics, and advanced AI.ROBOTICS Industry - MIRCOD AI-enabled robots are designed to work with scientists on a daily basis in a high demanding space at biotech laboratories. The MIRCOD autonomous robotic arms can be left alone to perform time-consuming biotechnological tasks in R&D biotech labs like setting up comprehensive predefined experiments in POC stations.HEALTHCARE Industry - MIRCOD team believes that today's remote monitoring technology isn't sufficiently advanced to predict a potential adverse event and alert a monitoring provider before disaster strikes. Our mission is to enhance these technologies and bring to the market an “ease of use” remote monitoring technology platform that enables continuous, configurable, wireless acquiring of biometric parameters from the human body. (Wherefore platform is not limited only to healthcare!) $700K / Seed / Jan 01, 2018
IoT and IoMT (Healthcare IoT) creation require ever-increasing and sophisticated electronic design. It also demands a superior level of expertise and necessitates the need for experienced and highly professional companies to expedite the development process. At the core of every electronic product is the electronics (hardware) and firmware(software) needed to run it.Mircod experience and multi-disciplines enable the company to provide turnkey development of: • Circuit Schematics: Analog & Digital, Gerber Artwork, and Layout Design. • Embedded Systems. • Firmware & Micro Controller Programming Software Design. • User-Interface Development. • Hardware Design for CE, FCE, UL, ROHS, WEEE, and FDA.The ability to provide the right, properly “up and running” comprehensive prototype for the desired idea, while selecting the precise components, defines all aspects of a product's performance, realistic proof of concept, durability, cost, and successful market penetration.MIRCOD brings together personnel with substantive expertise in all primary disciplines required to deliver the most complicated hardware and software solutions. This flexible and multi-skilled team brings an inherent understanding of the R&D in hardware and software related activities and the interfaces with other system delivery disciplines (mathematical algorithms, system engineering, sourcing, advanced materials, and manufacturing) required for success. MIRCOD also has the advantage of having worked on a diverse range of activities across a varied customer base in both production and prototyping capacities.BIOTECHNOLOGY Industry - MIRCOD actively participates in R&D projects initiated by international consortiums. Gene therapy technology developed in consideration with international top cell and gene biotech companies and universities, guarantees to transform tomorrow's medicine by treating the causes of disease rather than the manifestations.IoT Industry - We make the Internet of Things easy from Sketch to Scale. MIRCOD white-labeled rapid IoT web-based platform for rapid design, prototyping, design, and manufacturing is a hardware and software-agnostic system with white-label mobile apps, private BA and BI, complete device management, custom-defined analytics, and advanced AI.ROBOTICS Industry - MIRCOD AI-enabled robots are designed to work with scientists on a daily basis in a high demanding space at biotech laboratories. The MIRCOD autonomous robotic arms can be left alone to perform time-consuming biotechnological tasks in R&D biotech labs like setting up comprehensive predefined experiments in POC stations.HEALTHCARE Industry - MIRCOD team believes that today's remote monitoring technology isn't sufficiently advanced to predict a potential adverse event and alert a monitoring provider before disaster strikes. Our mission is to enhance these technologies and bring to the market an “ease of use” remote monitoring technology platform that enables continuous, configurable, wireless acquiring of biometric parameters from the human body. (Wherefore platform is not limited only to healthcare!) $1.3M / Seed / Dec 01, 2015

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Film
Oil and Gas
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Japan
Puerto Rico
Poland
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Bangladesh
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Michael Fainshtein invest in?

Michael Fainshtein invests primarily in Sensor, Robotics and Software startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Michael Fainshtein's check size?

Michael Fainshtein typically joins rounds of $700k–$1.3M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Michael Fainshtein participates in.

How do I contact Michael Fainshtein?

Public channels for Michael Fainshtein include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Michael Fainshtein last invest?

The most recent investment recorded for Michael Fainshtein closed in Jan 2018. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Michael Fainshtein Michael Fainshtein Find email